1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular TherapiesHemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmEnrolling by invitationNot stated2026-09-24NCT06208878